New Research Shows Automated Insulin Delivery Works Well for Older Adults

An automated insulin delivery (AID) system, sometimes called an artificial pancreas or closed-loop system, combines two main technologies: a continuous glucose monitor (CGM) and an insulin pump. The CGM—a small sensor worn on the arm or belly—continuously measures blood sugar levels and sends that data to a wearable insulin pump. The pump then automatically adjusts how much insulin is delivered based on real-time readings.

For people with type 1 diabetes, this automation can reduce the burden of constant glucose management and help keep blood sugar levels more stable throughout the day and night.

Older adults with type 1 diabetes have been largely left out of research studies on automated insulin delivery systems. This gap meant doctors and patients had limited evidence about how well these technologies work for older people. A new study from Washington State University and five other institutions included 78 older adults, making it one of the first to specifically examine both the safety and usability of AID systems in this population.

The research examined how easy the technology was to use and how effective it was at preventing hypoglycemia (low blood sugar) in older adults.

The study showed that automated insulin delivery systems are both safe and effective for older adults with type 1 diabetes. Many of the participants had been managing their diabetes with multiple daily injections for 30 years or more, so switching to technology-based management represented a significant change in their daily routine.

Despite the common assumption that older adults struggle with new technology, the study found that participants adapted well to using the closed-loop system. Lead researcher Professor Naomi Chaytor noted: "They did quite well" with the transition, challenging the stereotype that technology is harder for older adults.

Prior research has already shown that AID systems improve overall glucose control for people with type 1 diabetes. This new evidence in older adults suggests that automated insulin delivery can be a safe and effective option across age groups. As more older people are diagnosed with or have lived with type 1 diabetes for decades, ensuring they have access to and support for using modern technology becomes increasingly important.

Origin: diabetes.co.uk (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.